Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Good news from China ! CanSino is on final stage of Phase 3 testing,result is going to be came out soon ! All testing is carrying out on abroad since Covid-19 being control well in China. It is not surprise Solutn's share price is up today !
It is the beginning of good news coming,hopefully Solutn will run the project until the end. Of course, share price is up and up again day by day, all the best !
https://www.enanyang.my/node/373037 still valid or not? govn very confusing wan...if really direct supply why give such design approval in the first place...
CanSino has authorized SOLBIO to develop the business in Philippines, Vietnam, Thailand, Myanmar, Cambodia, Laos and Brunei (“Territory”), for their Recombinant Novel Coronavirus Vaccine candidate (Ad5-nCoV) composed of an adenovirus type 5 vector (Bulk Product presentation) (“Bulk Product”), by working with the respective local partners, authorities and regulatory bodies in the Territory in order to prepare the market for the Bulk Product, so that the Product can be sold when it is approved.
The above message mentioned that Solutn is aurhorize to develop the business in Philippines, Vietnam, Thailand, Myanmar, Cambodia, Laos and Brunei by CanSino.